Protagonist Therapeutics Inc (PTGX)

Jul 28, 2025

Protagonist therapeutics CEO Patel sells $570k in stock By Investing.com - Investing.com India

Jul 28, 2025

Jul 28, 2025

How does Protagonist Therapeutics Inc. generate profit in a changing economyDiscover top stock picks for aggressive growth - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

What is the dividend policy of Protagonist Therapeutics Inc. stockFree Stock Market Return Analysis - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

What are Protagonist Therapeutics Inc. company’s key revenue driversDaily Trading Picks Backed By Experts - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

What catalysts could drive Protagonist Therapeutics Inc. stock higher in 2025Capitalize on trading strategies that deliver - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

What institutional investors are buying Protagonist Therapeutics Inc. stockUnlock exclusive stock market forecasts - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Is Protagonist Therapeutics Inc. a growth stock or a value stockGame-changing returns - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Protagonist Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayShort Squeeze Radar - metal.it

Jul 27, 2025

Jul 26, 2025

Does Protagonist Therapeutics Inc. stock pay reliable dividendsFree Consultation - metal.it

Jul 26, 2025

Jul 25, 2025

Johnson & Johnson Submits NDA for Protagonist-Partnered Icotrokinra to FDA for Plaque Psoriasis - MSN

Jul 25, 2025

Jul 24, 2025

Protagonist Therapeutics Inc. Stock Analysis and ForecastExponentially increasing returns - PrintWeekIndia

Jul 24, 2025

Jul 24, 2025

What analysts say about Protagonist Therapeutics Inc. stockHigh-performance investment picks - PrintWeekIndia

Jul 24, 2025

Jul 24, 2025

Protagonist Therapeutics to Host Conference Call to Announce an Oral Obesity Development Candidate - Newport Daily News

Jul 24, 2025

Jul 23, 2025

CEO’s Major Stock Sale Shakes Up Protagonist Therapeutics! - TipRanks

Jul 23, 2025

Jul 23, 2025

Protagonist Therapeutics CEO Patel sells $2.88 million in shares By Investing.com - Investing.com India

Jul 23, 2025

Jul 23, 2025

Protagonist Therapeutics CEO Patel sells $2.88 million in shares - Investing.com

Jul 23, 2025

Jul 23, 2025

What drives Protagonist Therapeutics Inc. stock priceDynamic capital growth - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Is Protagonist Therapeutics Inc. a good long term investmentBreakout stock performance - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Protagonist Announces Submission of NDA for First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis - Lubbock Avalanche-Journal

Jul 22, 2025

Jul 21, 2025

Polycythemia Vera Pipeline 2025: Latest FDA Approvals, - openPR.com

Jul 21, 2025

Jul 21, 2025

Protagonist Announces Submission of NDA for First Icotrokinra U. - GuruFocus

Jul 21, 2025